Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Butler-Laporte

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
HLA|May 22, 2026
An Accurate Genetic Colocalisation Method for the HLA LocusGuillaume Butler-Laporte, Tianyuan Lu, Sam Morris, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 27, 2022
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysisAnthony D Bai, Carson K L Lo, Adam S Komorowski, et al.
Nature Genetics|January 12, 2023
Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseasesYiheng Chen, Tianyuan Lu, Ulrika Pettersson-Kymmer, et al.
Communications Biology|April 2, 2026
Author Correction: HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseasesGuillaume Butler-Laporte, Joseph Farjoun, Tomoko Nakanishi, et al.
Communications Biology|November 4, 2023
HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseasesGuillaume Butler-Laporte, Joseph Farjoun, Tomoko Nakanishi, et al.
Open Forum Infectious Diseases|October 2, 2020
Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED StudyGuillaume Butler-Laporte, Cedric P Yansouni, Katryn Paquette, et al.
JAMA Network Open|February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialEmily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infantsGuillaume Butler-Laporte, Kathryn Auckland, Zannatun Noor, et al.
Nature Genetics|January 24, 2025
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery diseaseSatoshi Yoshiji, Tianyuan Lu, Guillaume Butler-Laporte, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
HLA|May 22, 2026
An Accurate Genetic Colocalisation Method for the HLA LocusGuillaume Butler-Laporte, Tianyuan Lu, Sam Morris, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 27, 2022
Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysisAnthony D Bai, Carson K L Lo, Adam S Komorowski, et al.
Nature Genetics|January 12, 2023
Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseasesYiheng Chen, Tianyuan Lu, Ulrika Pettersson-Kymmer, et al.
Communications Biology|April 2, 2026
Author Correction: HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseasesGuillaume Butler-Laporte, Joseph Farjoun, Tomoko Nakanishi, et al.
Communications Biology|November 4, 2023
HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseasesGuillaume Butler-Laporte, Joseph Farjoun, Tomoko Nakanishi, et al.
Open Forum Infectious Diseases|October 2, 2020
Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED StudyGuillaume Butler-Laporte, Cedric P Yansouni, Katryn Paquette, et al.
JAMA Network Open|February 27, 2026
Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical TrialEmily G McDonald, Guillaume Butler-Laporte, James M Brophy, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2023
Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infantsGuillaume Butler-Laporte, Kathryn Auckland, Zannatun Noor, et al.
Nature Genetics|January 24, 2025
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery diseaseSatoshi Yoshiji, Tianyuan Lu, Guillaume Butler-Laporte, et al.
Pageof 9